Back to Search
PETER KRUK, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1366480634IndividualAccepts Medicare
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2000
Research & Publications (20)
A case study of "disorganized development" and its possible relevance to genetic determinants of aging.
PMID 19428454·Mech Ageing Dev·2009
5-case
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer.
PMID 19497997·Am J Pathol·2009
8-other
Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
PMID 19007973·Gynecol Oncol·2009
8-other
Deacetylation of cortactin by SIRT1 promotes cell migration.
PMID 18850005·Oncogene·2009
7-preclinical
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
PMID 18199536·Cancer Res·2008
8-other
Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
PMID 18365874·Growth Factors·2008
8-other
VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
PMID 17559911·Gynecol Oncol·2007
8-other
Vitamin E suppresses telomerase activity in ovarian cancer cells.
PMID 17335992·Cancer Detect Prev·2007
8-other
Telomerase confers resistance to caspase-mediated apoptosis.
PMID 18044112·Clin Interv Aging·2006
8-other
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
PMID 16894566·Int J Cancer·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8745 AERO DR, SUITE 200
SAN DIEGO, CA 92123 - Phone
- (858) 565-0950
Quick Facts
- NPI
- 1366480634
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 6
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile